Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026

Core Viewpoint - Harrow, a leading provider of ophthalmic disease management solutions in North America, will report its financial results for Q4 and the full year of 2025 on March 2, 2026, and will host a conference call on March 3, 2026, to discuss these results and provide a business update [1]. Group 1: Financial Reporting - The financial results for the fourth quarter and year ended December 31, 2025, will be announced after market close on March 2, 2026 [1]. - A Letter to Stockholders for the fourth quarter will be posted on the "Investors" section of Harrow's website [1]. Group 2: Conference Call Details - A conference call and live webcast will take place at 8:00 a.m. Eastern Time on March 3, 2026, to discuss the financial results and provide a business update [1]. - Participants can access the live webcast on the "Investors" page of Harrow's website, and a replay will be available for one year [2]. - Telephone participants must register in advance to receive a unique dial-in number and PIN for accessing the call [2]. Group 3: Company Overview - Harrow, Inc. is a prominent provider of ophthalmic disease management solutions, offering a comprehensive portfolio of products for various eye conditions, including dry eye disease, age-related macular degeneration, cataracts, refractive errors, glaucoma, and other ocular surface and retina diseases [3]. - The company is committed to delivering safe, effective, accessible, and affordable medications to enhance patient compliance and improve clinical outcomes [3].